Telix Pharmaceuticals Limited (TLX.AX)
AUD 25.67
(-0.27%)
AUD 25.67
(-0.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 496.65 Million | 160.09 Million | 7.59 Million | 5.21 Million | 3.48 Million | 195.14 Thousand |
| Cost of Revenue | 188.15 Million | 130.75 Million | 37.36 Million | 22.09 Million | 15.36 Million | - |
| Gross Profit | 308.5 Million | 29.33 Million | -29.76 Million | -16.87 Million | -11.87 Million | 195.14 Thousand |
| Operating Expenses | 269.26 Million | 102.51 Million | 51.48 Million | 32.37 Million | 28.38 Million | 27.84 Million |
| Selling, General and Administrative Expenses | 133.85 Million | 44.66 Million | 17.34 Million | 9.29 Million | 7.21 Million | 9.07 Million |
| Research and Development Expenses | 128.84 Million | 57.85 Million | 34.13 Million | 23.08 Million | 21.16 Million | 18.69 Million |
| Other Expenses | - | 3.08 Million | 23.55 Million | 2.95 Million | 11.44 Million | 11.62 Million |
| Cost and Expenses | 496.65 Million | 233.27 Million | 88.84 Million | 54.46 Million | 43.74 Million | 27.84 Million |
| Operating Income | - | -73.18 Million | -81.24 Million | -49.25 Million | -40.25 Million | -15.68 Million |
| Interest Expense | 13.13 Million | 406 Thousand | 189 Thousand | 1.17 Million | 2.4 Million | 29.01 Thousand |
| Income Tax Expense | -2.12 Million | 5.45 Million | -18.52 Million | -15.36 Million | -14.94 Million | -1.88 Million |
| Earnings before Tax | 3.08 Million | -98.62 Million | -99.03 Million | -60.25 Million | -42.81 Million | -15.71 Million |
| Net Income | 5.21 Million | -104.07 Million | -80.51 Million | -44.88 Million | -27.86 Million | -13.82 Million |
| Earnings Per Share Basic | 0.02 | -0.34 | -0.29 | -0.17 | -0.12 | -0.07 |
| Earnings Per Share Diluted | 0.02 | -0.34 | -0.29 | -0.17 | -0.12 | -0.07 |
| Weighted Average Shares Outstanding | 319.18 Million | 310.64 Million | 282.2 Million | 257.27 Million | 233.43 Million | 202.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 323.71 Million | 310.64 Million | 282.2 Million | 257.27 Million | 233.43 Million | 202.12 Million |
| Gross Margin | 0.62 | 0.18 | -3.92 | -3.24 | -3.41 | 1.00 |
| EBIT Margin | 0.05 | -0.42 | -10.01 | -8.51 | -10.34 | -80.34 |
| Profit Margin | 0.01 | -0.65 | -10.60 | -8.61 | -8.00 | -70.87 |
| EBITDA | 22.96 Million | -92.83 Million | -70.07 Million | -44.94 Million | -36.17 Million | -25.81 Million |
| Earnings Before Tax Margin | - | -0.46 | -10.70 | -9.45 | -11.55 | -80.38 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 188.96 Million | 496.65 Million | 281.71 Million | 220.83 Million | 160.09 Million | 136.04 Million |
| Cost of Revenue | 65.08 Million | 188.15 Million | 57.73 Million | 130.02 Million | 130.75 Million | 91.15 Million |
| Gross Profit | 123.88 Million | 308.5 Million | 223.97 Million | 90.81 Million | 29.33 Million | 44.89 Million |
| Operating Expenses | 110.12 Million | 269.26 Million | 203.9 Million | 59.37 Million | 102.51 Million | 54.59 Million |
| Selling, General and Administrative Expenses | 64.25 Million | - | 105.5 Million | 28.92 Million | - | 21.58 Million |
| Research and Development Expenses | 45.78 Million | - | 98.39 Million | 30.44 Million | - | 33.01 Million |
| Other Expenses | -96 Thousand | -29.33 Million | - | - | 3.08 Million | - |
| Cost and Expenses | 175.21 Million | 457.42 Million | 261.63 Million | 189.39 Million | 233.27 Million | 145.75 Million |
| Operating Income | 13.75 Million | 17.02 Million | 20.07 Million | 31.43 Million | -73.18 Million | -9.7 Million |
| Interest Expense | 4.94 Million | 13.13 Million | 548 Thousand | 442 Thousand | 406 Thousand | 268 Thousand |
| Income Tax Expense | -2.53 Million | -2.12 Million | -4.14 Million | 2.02 Million | 5.45 Million | 5.26 Million |
| Earnings before Tax | 9.14 Million | 3.08 Million | 15.38 Million | -12.3 Million | -98.62 Million | -27.91 Million |
| Net Income | 11.68 Million | 5.21 Million | 19.53 Million | -14.32 Million | -104.07 Million | -33.18 Million |
| Earnings Per Share Basic | 0.04 | - | 0.06 | -0.05 | - | -0.10 |
| Earnings Per Share Diluted | 0.03 | - | 0.06 | -0.05 | - | -0.10 |
| Weighted Average Shares Outstanding | 334.23 Million | 319.18 Million | 323.72 Million | 317.62 Million | 310.64 Million | 316.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 350.75 Million | 323.71 Million | 323.72 Million | 317.62 Million | 310.64 Million | 316.34 Million |
| Gross Margin | 0.66 | 0.62 | 0.80 | 0.41 | 0.18 | 0.33 |
| EBIT Margin | 0.08 | - | 0.08 | 0.16 | - | -0.05 |
| Profit Margin | 0.06 | 0.01 | 0.07 | -0.06 | -0.65 | -0.24 |
| EBITDA | 15.74 Million | - | 23.71 Million | 34.72 Million | - | -7.04 Million |
| Earnings Before Tax Margin | 0.07 | 0.03 | 0.07 | 0.14 | -0.46 | -0.07 |
TRH1V
BRAGF
0553
9880
A7A
CORE